Status:
UNKNOWN
Assessment of Renal Changes in Patients With Non Alcoholic Fatty Liver Disease
Lead Sponsor:
Assiut University
Conditions:
Non-Alcoholic Fatty Liver Disease
Chronic Kidney Diseases
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Assess the renal changes in patients with non-alcoholic fatty liver (NAFLD).
Detailed Description
* Non-alcoholic fatty liver disease (NAFLD) is the accumulation of fat (\>5%) in liver cells in the absence of excessive alcohol intake or other causes of liver disease. The histologic spectrum of NAF...
Eligibility Criteria
Inclusion
- •Patients diagnosed as NAFLD by abdominal ultrasonography, Fibroscan, NAFLD fibrosis score and FIB-4 score
Exclusion
- Patients with diabetes and/or hypertension.
- Patients with chronic renal disease.
- Patients with urinary tract infections.
- Patients on medications affecting the kidney (eg: NSAIDs,..etc)
- Patients with chronic liver disease other than NAFLD (chronic hepatitis; viral B,C, autoimmune etc).
- Alcohol consumption.
Key Trial Info
Start Date :
April 30 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 30 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03487068
Start Date
April 30 2018
End Date
May 30 2019
Last Update
April 4 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.